TFRC and acute myeloid leukemia: Our results suggest that although the TFRC expression levels in newly diagnosed and relapsed AML patients were consistent overall (GSE156008, GSE199451 and GSE153348; Additional file 1: Fig. S5b–d), the TFRC expression levels in AML cells in relapsed patients tended to increase (Additional file 1: Fig. S5c, d).